Search
for
Sort by
Research 30 of 1000+
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous adverse effects of targeted therapies
- Management of Toxicities of Targeted Therapies
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Editorial: Targeted immunological therapies in dermatology
- Multi Targeted Non Invasive Photoceutical Therapeutic Approach for Combat and Traumatic Soft Tissue Injuries
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- In Patients With Acne Vulgaris, How Do Standard Acne Treatments Combined With Adjunct Microbiome-Targeted Therapies Compare to Standard Acne Treatments Alone in Affecting Clinical Outcomes?
- Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
- Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Cutaneous adverse effects of targeted therapies
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- 0054 Treg-targeted therapies restrain disease in a murine model of alopecia areata
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Predictive value of the serum albumin change rate for therapeutic response to targeted therapy in patients with AIDS-related non-Hodgkin lymphoma
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Multimodal therapeutic approach for a severe case of kaposiform lymphangiomatosis from procedural interventions to targeted therapies
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies